| Diverse functional autoantibodies in patients with COVID-19 EY Wang, T Mao, J Klein, Y Dai, JD Huck, JR Jaycox, F Liu, T Zhou, ... Nature 595 (7866), 283-288, 2021 | 829 | 2021 |
| Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3 KSLC Jun Wang, Miguel F. Sanmamed, Ila Datar, Tina Tianjiao Su, Lan Ji ... cell 176 (1-2), 334-347.e12, 2019 | 671 | 2019 |
| IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy T Zhou, W Damsky, OE Weizman, MK McGeary, KP Hartmann, CE Rosen, ... Nature 583 (7817), 609-614, 2020 | 223 | 2020 |
| Enteric nervous system-derived IL-18 orchestrates mucosal barrier immunity A Jarret, R Jackson, C Duizer, ME Healy, J Zhao, JM Rone, P Bielecki, ... Cell 180 (1), 50-63. e12, 2020 | 160 | 2020 |
| Structural Basis for Hydroxymethylcytosine Recognition by the SRA Domain of UHRF2 T Zhou, X Jun, W Mingzhu, Y Na, W Jiemin, Z Bing, X Rui-Ming Molecular Cell 54 (5), 879-886, 2014 | 122 | 2014 |
| Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies T Zhou, TT Su, T Mudianto, J Wang Journal of Experimental Medicine 217 (10), e20200674, 2020 | 72 | 2020 |
| The intestinal parasite Cryptosporidium is controlled by an enterocyte intrinsic inflammasome that depends on NLRP6 A Sateriale, JA Gullicksrud, JB Engiles, BI McLeod, EM Kugler, ... Proceedings of the National Academy of Sciences 118 (2), e2007807118, 2021 | 44 | 2021 |
| Stella protein facilitates DNA demethylation by disrupting the chromatin association of the RING finger–type E3 ubiquitin ligase UHRF1 W Du, Q Dong, Z Zhang, B Liu, T Zhou, R Xu, H Wang, B Zhu, Y Li Journal of Biological Chemistry 294 (22), 8907-8917, 2019 | 30 | 2019 |
| NS3 from Hepatitis C Virus Strain JFH-1 Is an Unusually Robust Helicase That Is Primed To Bind and Unwind Viral RNA T Zhou, X Ren, R Adams, A Pyle Journal of Viology, 2017 | 15 | 2017 |
| Diverse Functional Autoantibodies in patients with COVID-19. medRxiv EY Wang, T Mao, J Klein, Y Dai, JD Huck, F Liu, NS Zheng, T Zhou, ... Preprint). Available online: https://www. medrxiv. org/content/10.1101/2020 …, 2021 | 10 | 2021 |
| IL-18BP mediates the balance between protective and pathological immune responses to Toxoplasma gondii JT Clark, OE Weizman, DL Aldridge, LA Shallberg, J Eberhard, Z Lanzar, ... Cell reports 42 (3), 2023 | 6 | 2023 |
| Interleukin-18 variants and methods of use A Ring, T Zhou, S Fischer https://patents.google.com/patent/US20190070262A1/en, 2019 | 2 | 2019 |
| Interleukin-18 variants and methods of use A Ring, T Zhou, S Fischer US Patent App. 18/180,389, 2023 | | 2023 |
| Interleukin-18 variants and methods of use A Ring, T Zhou, S Fischer US Patent App. 18/157,385, 2023 | | 2023 |
| Interleukin-18 variants and methods of use A Ring, T Zhou, S Fischer US Patent App. 18/055,581, 2023 | | 2023 |
| Interleukin-18 variants and methods of use R Aaron, T Zhou, S Fischer | | 2021 |
| Diverse Functional Autoantibodies that Underlie Immune Perturbations in COVID-19 T Mao, EY Wang, J Klein, Y Dai, JD Huck, F Liu, NS Zheng, T Zhou, ... The Journal of Immunology 206 (1_Supplement), 114.04-114.04, 2021 | | 2021 |
| composição, e, método para tratar ou prevenir uma doença ou distúrbio em um indivíduo em necessidade do mesmo. A Ring, T Zhou, S Fischer | | 2020 |
| VARIANTS OF INTERLEUKIN-18 AND METHODS OF USE R Aaron, T Zhou, S Fischer | | 2019 |
Jun WangAssistant Professor of Pathology, New York University (NYU) Grossman School of MedicineVerified email at nyulangone.org
